28 June 2011 /Prices and reimbursement
On 27 June 2011, the Danish Medicines Agency decided on the future reimbursement status of medicines in ATC group C05 (vasoprotectives). These medicines will still not be eligible for general reimbursement.
14 June 2011 /Prices and reimbursement
The Danish Medicines Agency has completed its review of an application for general reimbursement for Efient®. The product has been granted general reimbursement.